Evans, AR and Airley, R (2012) How the science of personalized medicines will change the clinical management of patients in the pharmacy. Future Medicinal Chemistry, 4 (16). pp. 2023-2027. ISSN 1756-8919
Preview |
Text
How the Science of Personalised Medicines Will Change the Clinical Management of Patients in the Pharmacy.pdf - Accepted Version Download (150kB) | Preview |
Abstract
The prescribing and dispensing of medication is currently a one-size fits all process and by association, the average pharmacy will contain an anthology of one-size fits all packets of 28 oral dose forms, which will be in turn labelled according to a pile of one-size-fits all prescriptions detailing rigidly indicated dosage regimens. The trouble is, unlike pharmaceutical dose forms, patients are not rigidly quality controlled by the pharmaceutical industry to ensure consistency. With evidence-based medicine, there has been a standardisation of patient care to a certain extent. When it comes to medicines however, we have to consider whether the clinical trials upon which we base our evidence and therefore compile the often strict prescribing guidelines in use by the National Health Service in the UK and other health systems internationally, are inherently flawed when they too are based upon the assumption that patients are homogenous in their response to medication.
Item Type: | Article |
---|---|
Subjects: | R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica |
Divisions: | Pharmacy and Biomolecular Sciences |
Publisher: | Future Science |
Date of acceptance: | 1 September 2012 |
Date of first compliant Open Access: | 17 February 2016 |
Date Deposited: | 17 Feb 2016 09:25 |
Last Modified: | 04 Sep 2021 13:49 |
DOI or ID number: | 10.4155/fmc.12.129 |
URI: | https://ljmu-9.eprints-hosting.org/id/eprint/2333 |
![]() |
View Item |